Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
American Journal of Clinical Pathology|August 22, 2019
Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic LeukemiaBianca M Van Der Nest, Connull Leslie, David Joske, et al.Journal of Clinical Pathology|July 2, 2010
More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitisStephen Lee, W Bastiaan de Boer, Anupam Naran, et al.Asia-Pacific Journal of Clinical Oncology|December 16, 2025
Prolonged Survival in Anaplastic Thyroid Cancer: Insights From Multi-Modal TreatmentBella Nguyen, Richard Gauci, Connull Leslie, et al.Pigment Cell & Melanoma Research|December 22, 2016
Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanomaNima Mesbah Ardakani, Connull Leslie, Fabienne Grieu-Iacopetta, et al.Pathology|August 27, 2015
FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitorConnull Leslie, Samantha E Bowyer, Alison White, et al.American Journal of Surgery|April 5, 2024
Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinomaDavid Leong, Connull Leslie, Brodie Laurie, et al.Pathology|July 9, 2015
BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility studyConnull Leslie, Fabienne Grieu-Iacopetta, Anna Richter, et al.Scientific Reports|February 18, 2021
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancerBella Nguyen, Nicholas C Wong, Tim Semple, et al.Diagnostic Cytopathology|April 2, 2014
Anaplastic large-cell lymphoma associated with breast implants: a unique entity within the spectrum of peri-implant effusionsSiaw Ming Chai, Simon Kavangh, Sin Sin Ooi, et al.Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.Pageof 4